<DOC>
	<DOC>NCT00328393</DOC>
	<brief_summary>The anti-diabetic pioglitazone has been found to reduce casual blood pressure. To date, no data are available looking at this effect in detail. Especially, ambulatory blood pressure has not yet been utilized to confirm the hypothesis that pioglitazone has blood pressure lowering effects.</brief_summary>
	<brief_title>Effect of Pioglitazone on Ambulatory Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Age 4575 years Diabetes mellitus Type 2 (HbA1c 7 8.5%) Casual blood pressure &gt; = 130/80 mmHg, &lt; 160/100 mmHg Therapy with insulin Combination therapy of sulfonylurea und metformin Therapy with nateglinid, repaglinid or an other substance of this drug family Allergy against pioglitazone or other composites of the tablet History of heart failure (NYHA I bis IV) Hepatic insufficiency Transaminases &gt; 2.5fold of the upper normal limit Endstage renal failure Syndrome of polycystic ovaries Absence of effective contraception in women of childbearing potential Pregnancy or breastfeeding</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Hypertension</keyword>
</DOC>